MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.isci.2026.116031

Медицинская библиотека · iScience · 2026

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells.

Barcelo Jaume, Teigen Yumiko, Martin Joshua Alexander James, George Samantha, Das Dipanwita, Sewell Joanne, Perdrix-Rosell Anna, Bewicke-Copley Findlay, Ghose Ritobrata, Yang William, Brough Rachel, Clear Andrew, Walter Wencke, Haferlach Torsten, Malanchi Ilaria, Gribben John G, van de Lagemaat Louie N, Kranc Kamil R, Lord Christopher J, Rio-Machin Ana, Maiques Oscar, Fitzgibbon Jude, Sanz-Moreno Victoria

СтатьяПеревод в очереди

Аннотация

Although Rho kinase (ROCK) has been studied in tumor progression, the reliance of some cancer cells on ROCK-Myosin II for survival remains poorly understood. Using systematic analysis of ROCK inhibitor sensitivity in hundreds of cancer cell lines, we find that ROCK inhibition reduces survival of highly de-differentiated, invasive cancer cells from solid tumors. Transcriptomic analysis reveals enrichment in epithelial-to-mesenchymal transition, migration, proliferation, and inflammation genes, with reduced expression of differentiation and cell-cell junction genes like E-cadherin (CDH1). Acute myeloid leukemia (AML) shows high ROCK inhibitor response among hematological malignancies. Using in vitro and in vivo approaches, we validate biomarkers of ROCK inhibitor sensitivity in breast cancer, melanoma, and AML, demonstrating their unique addiction to Rho-ROCK-myosin II signaling for survival. Our work has important pre-clinical implications while cautions against wider use of ROCK inhibitors in patient-derived organoid cultures, where they may deplete important cancer cell populations.

Для цитирования: Barcelo Jaume, Teigen Yumiko, Martin Joshua Alexander James, George Samantha, Das Dipanwita, Sewell Joanne, Perdrix-Rosell Anna, Bewicke-Copley Findlay, Ghose Ritobrata, Yang William, Brough Rachel, Clear Andrew, Walter Wencke, Haferlach Torsten, Malanchi Ilaria, Gribben John G, van de Lagemaat Louie N, Kranc Kamil R, Lord Christopher J, Rio-Machin Ana, Maiques Oscar, Fitzgibbon Jude, Sanz-Moreno Victoria. Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells.. iScience. 2026. DOI: 10.1016/j.isci.2026.116031.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.